Goldman Sachs Group Inc Galera Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$0.17 - $3.0 $2,035 - $35,922	11,974 New	11,974 $2,000
Q3 2023 Nov 14, 2023	SELL	$0.17 - $3.0 $3,370 - $59,484	-19,828 Reduced 62.35%	11,974 $2,000
Q2 2023 May 14, 2024	BUY	$2.5 - $3.42 $51,217 - $70,065	20,487 Added 181.06%	31,802 $99,000
Q2 2023 Aug 14, 2023	BUY	$2.5 - $3.42 $51,217 - $70,065	20,487 Added 181.06%	31,802 $99,000
Q1 2023 May 14, 2024	SELL	$1.48 - $2.68 $71 - $128	-48 Reduced 0.42%	11,315 $28,000
Q1 2023 May 11, 2023	SELL	$1.48 - $2.68 $71 - $128	-48 Reduced 0.42%	11,315 $28,000
Q4 2022 May 14, 2024	SELL	$1.34 - $1.78 $123 - $163	-92 Reduced 0.8%	11,363 $16,000
Q4 2022 Feb 13, 2023	SELL	$1.34 - $1.78 $123 - $163	-92 Reduced 0.8%	11,363 $16,000
Q3 2022 May 14, 2024	SELL	$1.15 - $2.1 $209 - $382	-182 Reduced 1.56%	11,455 $20,000
Q3 2022 Nov 10, 2022	SELL	$1.15 - $2.1 $209 - $382	-182 Reduced 1.56%	11,455 $0
Q2 2022 May 14, 2024	BUY	$1.24 - $2.39 $14,429 - $27,812	11,637 New	11,637 $15,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.39 $5,209 - $10,040	-4,201 Reduced 26.52%	11,637 $15,000
Q1 2022 May 16, 2022	SELL	$2.01 - $4.19 $12,685 - $26,443	-6,311 Reduced 28.49%	15,838 $38,000
Q4 2021 Feb 14, 2022	BUY	$1.27 - $8.28 $13,243 - $86,343	10,428 Added 88.97%	22,149 $102,000
Q3 2021 Nov 10, 2021	BUY	$7.04 - $10.49 $82,515 - $122,953	11,721 New	11,721 $95,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $2.15M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.